期刊文献+

同期与分期双膝关节置换术后并发症发生率的临床研究 被引量:7

Clinical Study of the Incidence of Complications in One-stage and Two-stage Double Knee Arthroplasty
下载PDF
导出
摘要 目的:比较同期双侧膝关节置换和分期双侧膝关节置换的不良后果发生率和膝关节功能恢复情况。方法:将本院2012年6月-2014年6月行双膝关节置换术的患者分为同期双侧全膝关节置换术组和分期双侧全膝关节置换术组,比较术后两组患者的死亡率、心脑血管系统及下肢血管栓塞的发生率、膝关节伤口感染情况等及手术治疗半年后膝关节功能的恢复情况。结果:同期手术组和分期手术组术前合并症比较,差异无统计学意义。两组患者术前、术后半年HSS评分比较无统计学意义。同期手术组与分期手术组患者的术后并发症发生率经比较,差异无统计学意义。结论:同期与分期行双膝关节置换的患者具有相同的手术安全性和术后的临床效果。 Objective:To compare the adverse consequences of simultaneous bilateral total knee replacement and staged bilateral total knee replacement and the degree of functional recovery of knee joint. Method:From June 2012 to June 2014 in our hospital,the patients were divided into bilateral total knee arthroplasty group and staged bilateral total knee arthroplasty group. To compare the two groups with postoperative mortality,cardiovascular system complication rate,lower extremity arterial embolism complication rate,periprosthetic infection and postoperative knee function recovery. Result:The preoperative complications had no significant difference between the two groups,with no statistical significance. The preoperative HSS score had no significant difference between the two groups. The postoperative HSS score had no significant difference between the two groups. Between the two groups,postoperative complication rate showed no significant difference,with no statistical significance. Conclusion:In the two groups,the clinical effect and safety of operation are the same after the operation.
作者 张喜龙
出处 《中国医学创新》 CAS 2014年第31期60-62,共3页 Medical Innovation of China
关键词 全膝关节置换术后 同期 分期 并发症 Total knee arthroplasty One-stage Two-stage Complications
  • 相关文献

参考文献15

二级参考文献64

  • 1赵辉.预防全膝关节置换术后深静脉血栓形成的护理对策[J].中原医刊,2006,33(16):91-92. 被引量:7
  • 2陈兰玉.人工膝关节置换术围手术期护理及下肢深静脉血栓形成的预防[J].中国中医急症,2006,15(9):1056-1057. 被引量:1
  • 3庄心良,曾因明,陈伯銮,主编.现代麻醉学.第3版.北京:人民卫生出版社,2004:2610-2612.
  • 4Desjardins PJ, Grossman EH, Kuss ME, et al. The injectable cyclooxygenase- 2 specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively. Anesth Analg,2001,93 (3) :721 - 727.
  • 5Tang J, Li S, White PF, et al. Effect of parecoxib, a novel intravenous cyclooxygenase type- 2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology 2002, 96 ( 6 ) : 1305 - 1309.
  • 6White RH, Henderson MC. Risk factors for venous thromboembolism after total hip and knee replacement surgery. Current Opinion in Pulmonary Medicine,2002,8(5 ) :365 - 371.
  • 7Maheshwari AV, Blum YC, Shekhar L, et al. Multimodal pain management after total hip and knee arthroplasty at the Ranawat orthopaedic center. Clin Orthop Relat Res,2009,467(6) :1418 -1423.
  • 8Akritopoulos P, Papaioannidou P, Hatzokos I, et al. Parecoxib has non - significant longterm effects on bone healing in rats when ad- ministered for a short period after fracture. Arch Orthop Trauma Surg, 2009,129(10) : 1427 - 1432.
  • 9Reuben SS, Ekman EF, Raghunathan K, et al. The effect of cyclooxy- genase - 2 inhibition on acute and chronic donorsite pain after spinal - fusion surgery. Reg Anesth pain Med,2006,31 ( 1 ) :6 - 13.
  • 10Viscusi ER, Gimbel JS, Halder AM, et al. A multiple -day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty. Anesth Analg,2008,107 (2) :652 - 660.

共引文献615

同被引文献83

  • 1王和鸣.中医骨伤科临床标准制订的背景与建议[J].中国中医骨伤科杂志,2006,14(6):1-2. 被引量:4
  • 2Kurtz S,Ong K,Lau E,et al.Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to2030[J].J Bone Joint Surg Am,2007,89(4):780-785.
  • 3Alshryda S,Sukeik M,Sarda P,et al.A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement[J].Bone Joint J,2014,96-B(8):1005-1015.
  • 4Pornrattanamaneewong C,Narkbunnam R,Siriwattanasakul P,et al.Three-hour interval drain clamping reduces postoperative bleeding in total knee arthroplasty:a prospective randomized controlled trial[J].Arch Orthop Trauma Surg,2012,132(7):1059-1063.
  • 5Lin D M,Lin E S,Tran M H.Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management:a systematic review[J].Transfus Med Rev,2013,27(4):221-234.
  • 6Zhou X D,Tao L J,Li J.Do we really need tranexamic acid in total hip arthroplasty?A meta analysis of nineteen randomized controlled trials[J].Arch Orthop Trauma Surg,2013,133(7):1017-1027.
  • 7Hewitt B,Shakespeare D.Flexion vs.extension:a comparison of post-operative total knee arthroplasty mobilisation regimes[J].Knee,2001,8(4):305-309.
  • 8Madarevic T,Tudor A,Sestan B,et al.Postoperative blood loss management in total knee arthroplasty:a comparison of four different methods[J].Knee Surg Sports Traumatol Arthrosc,2011,19(6):955-959.
  • 9Gross J B.Estimating allowable blood loss:corrected for dilution[J].Anesthesiology,1983,58(3):277-280.
  • 10Ma T,Khan R J,Carey Smith R,et al.Effect of flexion/extension splintage post total knee arthroplasty on blood loss and range of motion-a randomised controlled trial[J].Knee,2008,15(1):15-19.

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部